Martin Blake Email & Phone Number
@perthradclinic.com.au
LinkedIn matched
Who is Martin Blake? Overview
A concise factual answer block for searchers comparing this professional profile.
Martin Blake is listed as Chairperson at DermCo Pty Ltd, a with 11 employees, based in Greater Perth Area, Australia. AeroLeads shows a work email signal at perthradclinic.com.au and a matched LinkedIn profile for Martin Blake.
Martin Blake previously worked as Board Member at Western Australia National Imaging Facility and Founding Director at Syngenis. Martin Blake holds Master Of Business Administration (Mba) from University Of Melbourne - Melbourne Business School.
Email format at DermCo Pty Ltd
This section adds company-level context without repeating Martin Blake's masked contact details.
AeroLeads found 2 current-domain work email signals for Martin Blake. Compare company email patterns before reaching out.
About Martin Blake
Experienced Chairperson with a demonstrated history of working in the hospital & health care industry. Skilled in Medical Devices, Healthcare, Medical Imaging, Commercialization, and Radiology. Strong business development professional graduated from University of Melbourne - Melbourne Business School.
Listed skills include Healthcare, Management Consulting, Commercialization, Medical Devices, and 2 others.
Martin Blake's current company
Company context helps verify the profile and gives searchers a useful next step.
Martin Blake work experience
A career timeline built from the work history available for this profile.
Board Member
CurrentNIF provides state-of-the-art imaging capabilities for the imaging of human, animals, plants, and materials through three main themes of: Animals, Plants and Materials Imaging, Human Imaging, Molecular Imaging and Radiochemistry.https://anif.org.au/about/nodes/uwa/
Chairperson
CurrentDermCo (https://dermco.com.au) is growing a nationwide network of Dermatology practices, synonymous with clinical quality.The group is entirely doctor-led and is highly inclusive of Dermatologists at every stage of professional life. The majority of DermCo shareholders are Dermatologists in current clinical practice. Joining Dermatologists can become Partners who share in the profits of the group, and may invest if they wish.DermCo seeks to provide a consistently excellent experience for Dermatologists and their patients, and to meaningfully improve access to care. We use the scale of a larger group to take on ambitious projects and new clinical initiatives in Dermatology, guided by input from Partners, Shareholders and our independent Clinical Council of elected Dermatologists.
Founding Director
CurrentSynGenis has advanced manufacturing capability to make oligonucleotides for diagnostic purposes: DNA Probes, PCR primers and aptamers; oligonucleotides for therapeutic development; antisense oligonucleotides, siRNAs, microRNAs, antagomiRs, and antimiRs; and oligonucleotides for drug delivery. The company, through the knowledge and expertise in production chemistry of Associate Professor Rakesh Veedu, will be able to support the research & development initiatives of universities and their affiliated institutes, pharma companies, and the diagnostic sector around the world. Visit us at https://www.syngenis.com
Chairman
CurrentResonance Health is a healthcare company listed on the Australian Stock Exchange (ASX:RHT). Resonance Health provides quantitative MRI based technologies for the diagnosis and monitoring of human disease. FerriScan® was the first product brought to market and provides an accurate non-invasive assessment of liver iron, largely removing the need for a liver biopsy in many patients with iron overload conditions. HepaFat-Scan® gained FDA clearance in December 2013 for the measurement of fatty liver and development of an MRI based method to assess liver fibrosis continues as part of the Company's focus on developing diagnostic products to address liver disease. The company is now using Artificial Intelligence techniques to add to its suite of product offerings.
Director
CurrentPivotree is a Western Australian start-up commercialising the Pivotree Small Oilfield Production System, which creates a step-change in small field development and production economics to unlock stranded oil field assets.The system combines novel patent-pending components with conventional subsea oil and gas equipment, eliminating the need for conventional oilfield infrastructure or access to a subsea pipeline, and eliminates the need for significant structural changes to the off-take vessel. Operating expense is reduced by reduced fuel, consumables and labour costs, and creating flexibility in the production process. The result is a 50-70% reduction in CAPEX and OPEX requirements for a field development. Importantly the Pivotree system decreases the time from drilling to production, which greatly improves the net present value for such investments.This value proposition can be applied to unlock:1. fully stranded assets that cannot justify full field development;2. marginal or partially stranded assets that are too remote for tieback to existing infrastructure; and,3. capturing remaining value in ageing assets where the asset has useful life but the cost of additional tie-backs exceed the total revenue expected.The key inventions underpinning the system and enabling elimination of conventional infrastructure are subject to provisional patent applications and therefore remain confidential at this time. Disclosure of details could be made under a suitable undertaking of confidentiality.Designed for the low oil-price environment, this novel system is a step change in development and production economics, unlocking both stranded small oil fields around the globe with reserves of less than 25MMbbls, that are more than 10kms from export infrastructure, or that are in more than 150m of water.
Chairman
CurrentThe PerthRadClinic Foundation was founded in 2014 to foster improvement in social and healthcare outcomes for the Western Australian community by supporting innovation in medicine, health education, community programs, and staff participation in charitable activities.During the month of April we have introduced the "steps towards better health" across our 20 clinics and we will be promoting the PerthRadClinic Foundation and the Harry Perkins Institute of Medical Research. We hope that by working together with the Harry Perkins Institute we can make an impact on their research by supplying much needed funding and at the same time make a small improvement in our own fitness levels. The Foundation will donate 1c for every step averaged over the month.
Director
CurrentShenton House Pty Ltd is a joint venture between partners of Perth Radiological Clinic and the Perth Diocesan Trustee which has built, owns and operates Shenton House at 57 Shenton Avenue, Joondalup directly opposite Joondalup Health Campus. It is a 6000sq m purpose built multistorey centre and houses medical imaging, cancer treatment, medical and allied health professionals, general offices, a café and an Anglican Church on-site.
Director
ProGenis Pharmaceuticals is focused on developing next generation RNA therapeutics including splice switching antisense oligonucleotide drugs that are more efficient, safer and accessible to treat inherited rare and acquired diseases. ProGenis is headquartered in Perth, Australia, and led by world-renowned experts with significant experience in RNA therapeutics including antisense oligonucleotide chemistries and manufacturing.
Chairperson
SpaceDraft provides visual tools for creatives to plan anything, share anywhere.To meet the increasing demand for quality content, creatives need an intuitive, modern collaboration tool to help them customise and share concepts for virtual space. See what you can build on our 2D, 3D, and 4D digital sharable canvasses. SpaceDraft.com
Chairman
Perth Radiological Clinic is the oldest established private medical imaging practice in Perth with 20 branches located in community and hospital settings, including the provision of medical imaging services to four private hospitals and four public hospitals. The company has over 90 medical specialists and 1000 employees. PRC is a partner-owned business and aims to provide the highest standard of diagnostic medical imaging with an unwavering focus on accuracy, professionalism, convenience and affordability.
Martin Blake education
Master Of Business Administration (Mba)
Bachelor Of Medicine, Bachelor Of Surgery (Mbbs)
Faanms
Gaicd
Franzcr
Frequently asked questions about Martin Blake
Quick answers generated from the profile data available on this page.
What company does Martin Blake work for?
Martin Blake works for DermCo Pty Ltd.
What is Martin Blake's role at DermCo Pty Ltd?
Martin Blake is listed as Chairperson at DermCo Pty Ltd.
What is Martin Blake's email address?
AeroLeads has found 2 work email signals at @perthradclinic.com.au for Martin Blake at DermCo Pty Ltd.
Where is Martin Blake based?
Martin Blake is based in Greater Perth Area, Australia while working with DermCo Pty Ltd.
What companies has Martin Blake worked for?
Martin Blake has worked for Dermco Pty Ltd, Western Australia National Imaging Facility, Syngenis, Resonance Health Ltd, and Pivotree (Australia).
How can I contact Martin Blake?
You can use AeroLeads to view verified contact signals for Martin Blake at DermCo Pty Ltd, including work email, phone, and LinkedIn data when available.
What schools did Martin Blake attend?
Martin Blake holds Master Of Business Administration (Mba) from University Of Melbourne - Melbourne Business School.
What skills is Martin Blake known for?
Martin Blake is listed with skills including Healthcare, Management Consulting, Commercialization, Medical Devices, Medical Imaging, and Radiology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trialCheck these profiles if this is not the Martin Blake you were looking for.
View similar profiles